PFE Stock Quote - Pfizer Inc Stock News, ResearchWarren Buffett Guru Investors

28.78 (1y: +29%)

Market Cap	203.58 B	P/E(ttm)	13.90
Enterprise Value	208.64 B	P/B	2.60

PFE- NYSE (USA)
Pfizer Inc

Currently 3/5

Business Predictability Rank: 3-Star (On Watch)
Back Testing Results:
Average gain of all 3-Star stocks: 8.2% per year.
% of Stocks that are in still loss if held for 10yrs: 11%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$28.78

2 Severe Warning Signs 4 Medium Warning Signs 2 Good Signs

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	203,576	Revenue $M	57,601	Net Margin (%)	24.7	Z-Score	2.4
Enterprise Value $M	208,645	EPS $	2.1	Operating Margin %	20.5	F-Score	7
P/E(ttm))	13.9	Cash Flow Per Share $	3.5	Pre-tax Margin (%)	20.5	Higher ROA y-y	Y
Price/Book	2.6	10-y EBITDA Growth Rate %	4.9	Quick Ratio	1.8	Cash flow > Earnings	Y
Price/Sales	3.7	5-y EBITDA Growth Rate %	4.4	Current Ratio	2.0	Lower Leverage y-y	Y
Price/Cash Flow	7.2	y-y EBITDA Growth Rate %	-21.3	ROA % (ttm)	7.8	Higher Current Ratio y-y	Y
Dividend Yield %	3.2	Insider Buy (3m)	0	ROE % (ttm)	17.9	Less Shares Outstanding y-y	N
Payout Ratio %	63.5	Shares Outstanding M	7,189	ROI % (ttm)	14.8	Gross Margin Increase y-y	Y

Gurus Latest Trades with PFE

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Number of guru portfolios checked: 51.

Total Records: 167 Page: FIRST

5 6 7 8 9

No Entry found!

Total Records: 167 Page: FIRST

5 6 7 8 9

PFE is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus

Ticker	Guru Name	Portfolio Date*	Current Shares	% of Shares Outstanding	% of Total Assets Managed	Change from Last Holdings
PFE	Jean-Marie Eveillard	2013-03-31	6,562,712	0.09	0.63	+57.8%
PFE	Joel Greenblatt	2013-03-31	54,322	0	0.08	+16.68%
PFE	James Barrow	2013-03-31	58,282,831	0.81	3	+0.51%
PFE	Yacktman Fund	2013-03-31	7,800,000	0.11	2.65
PFE	George Soros	2013-03-31	165,000	0	0.06
PFE	Yacktman Focused Fund	2013-03-31	5,600,000	0.08	2.21
PFE	Prem Watsa	2013-03-31	235,000	0	0.25
PFE	Ruane Cunniff	2013-03-31	9,147	0	0	-0.74%
PFE	John Keeley	2013-03-31	104,425	0	0.06	-1.22%
PFE	Dodge & Cox	2013-03-31	69,759,556	0.97	2.5	-2.09%
PFE	Donald Yacktman	2013-03-31	16,239,945	0.23	2.4	-2.8%
PFE	Ronald Muhlenkamp	2013-03-31	36,364	0	0.22	-3.35%
PFE	Vanguard Health Care Fund	2013-03-31	31,600,488	0.44	3.6	-5.34%
PFE	Mario Gabelli	2013-03-31	1,153,774	0.02	0.21	-6.71%
PFE	Charles Brandes	2013-03-31	6,672,418	0.09	2.3	-8.44%
PFE	Michael Price	2013-03-31	592,100	0.01	2.2	-9.89%
PFE	David Dreman	2013-03-31	90,867	0	0.07	-18.14%
PFE	Ray Dalio	2013-03-31	57,808	0	0.02	-26.27%

Most recent portfolio changes are included for Premium Members only!

PFE: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
SCHULMAN AMY W	Executive Vice President	2013-05-15	Sell	70,000	$29.36	-3.17	view
READ IAN C	Chairman & CEO	2013-05-15	Sell	69,900	$29.39	-3.27	view
DAMELIO FRANK A	Executive Vice President	2013-05-15	Sell	100,000	$29.33	-3.07	view
Germano Geno J	Business Unit President	2013-03-14	Sell	40,000	$28	1.54	view
LANKLER DOUGLAS M	Executive Vice President	2013-03-13	Sell	15,000	$28	1.54	view
MADDALUNA ANTHONY J	Executive Vice President	2013-03-08	Sell	19,000	$28.15	0.99	view
BRANDICOURT OLIVIER	Business Unit President	2013-03-06	Sell	113,364	$28.14	1.03	view
HILL CHARLES H	Executive Vice President	2013-03-06	Sell	21,812	$28.08	1.25	view
Dolsten Mikael	President R&D	2013-03-06	Sell	30,582	$28.11	1.14	view
SUSMAN SALLY	Executive Vice President	2013-03-06	Sell	53,196	$28.13	1.07	view

Press Releases about PFE:

Pfizer Presents Phase 3 Safety And Immunogenicity Data On... 04 Mar 2013
Nodality, Inc. Expands Senior Team, Appoints Guy Cavet,... 04 Mar 2013
Pfizer Inc. Issues Statement on ZoetisTM IPO 01 Feb 2013
Pfizer Reports Fourth-Quarter and Full-Year 2012 Results;... 29 Jan 2013
Pfizer Receives FDA Approval For The Use Of Prevnar 13 In... 25 Jan 2013

Quarterly/Annual Reports about PFE:

10-Q - PFIZER INC (0000078003) (Filer): (10-Q) 09 Nov 2012
10-Q - PFIZER INC (0000078003) (Filer): (10-Q) 09 Aug 2012
10-Q - PFIZER INC (0000078003) (Filer): (10-Q) 10 May 2012
10-K - PFIZER INC (0000078003) (Filer): (10-K) 28 Feb 2012
10-Q - PFIZER INC (0000078003) (Filer): (10-Q) 10 Nov 2011

News about PFE:

Articles On GuruFocus.com

20 Mega Caps and Their Dividend Payments and Which to Consider May 17 2013

3 Dogs of the Dow With Highest Earnings Growth Apr 27 2013

100 Most-Sold Stocks by Famous Investment Gurus Apr 11 2013

20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013

3 Dogs of the Dow with the Highest Expected Earnings Growth Mar 27 2013

10 Best Dividend Paying Drug Manufacturing Stocks Mar 02 2013

My 3 Favorite Dogs of the Dow Jones Feb 26 2013

Why I Want You to Take an Axe to Your Dividend Stock Portfolio Feb 06 2013

2013: Breakout or Comeuppance? Jan 28 2013

The Best Dogs of the Dow Jones as of December 2012 Dec 26 2012

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles